Trevi Therapeutics, Inc. (TRVI) Ownership

$6.85

$0.27 (4.03%)
Last update: 01:34 PM EST
Day's range
$6.35
Day's range
$6.87

Trevi Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
NEA MANAGEMENT COMPANY, LLC 05/14/2025 11.37 M $71.52 M   0.00% 9.67%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 05/15/2025 10.26 M $64.53 M   -3.80% 8.72%
BLACKROCK, INC. 05/02/2025 5.31 M $33.42 M   35.23% 4.52%
RUBRIC CAPITAL MANAGEMENT LP 05/14/2025 4.54 M $28.55 M   7.93% 3.86%
VANGUARD GROUP INC 05/09/2025 3.84 M $24.14 M   9.37% 3.26%
VIVO CAPITAL, LLC 05/12/2025 3.49 M $21.94 M   0.00% 2.97%
BIOIMPACT CAPITAL LLC 05/15/2025 3.43 M $21.56 M   10.77% 2.92%
OCTAGON CAPITAL ADVISORS LP 05/16/2025 3.32 M $20.90 M   100.00% 2.82%
VIKING GLOBAL INVESTORS LP 05/15/2025 3.23 M $20.30 M   -26.64% 2.74%
ARMISTICE CAPITAL, LLC 05/15/2025 2.99 M $18.79 M   100.00% 2.54%
SIREN, L.L.C. 05/23/2025 2.86 M $18.01 M   -1.45% 2.44%
MARSHALL WACE, LLP 05/15/2025 2.55 M $16.07 M   5,850.98% 2.17%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2025 2.37 M $14.89 M   -42.94% 2.01%
05/19/2025 2.14 M $13.49 M   7.19% 1.82%
WOODLINE PARTNERS LP 05/15/2025 2.06 M $12.94 M   -35.95% 1.75%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2025 1.76 M $11.06 M   100.00% 1.50%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 1.61 M $10.16 M   24.29% 1.37%
STATE STREET CORP 05/15/2025 1.42 M $8.96 M   21.68% 1.21%
MAI CAPITAL MANAGEMENT 05/15/2025 1.39 M $8.71 M   2.08% 1.18%
AFFINITY ASSET ADVISORS, LLC 05/14/2025 1.25 M $7.86 M   100.00% 1.06%
CAPTION MANAGEMENT, LLC 05/15/2025 1.12 M $7.07 M   100.00% 0.96%
ORBIMED ADVISORS LLC 05/15/2025 1.12 M $7.04 M   100.00% 0.95%
INVESCO LTD. 05/12/2025 852.99 K $5.37 M   3,511.13% 0.73%
MILLENNIUM MANAGEMENT LLC 05/15/2025 823.25 K $5.18 M   356.30% 0.70%
OPALEYE MANAGEMENT INC. 05/15/2025 795.00 K $5.00 M   -65.70% 0.68%
ACUTA CAPITAL PARTNERS, LLC 05/15/2025 785.96 K $4.94 M   1.81% 0.67%
ALLY BRIDGE GROUP (NY) LLC 05/15/2025 686.22 K $4.32 M   -12.19% 0.58%
VR ADVISER, LLC 05/15/2025 615.51 K $3.87 M   -51.40% 0.52%
ROSALIND ADVISORS, INC. 05/14/2025 612.90 K $3.86 M   -42.32% 0.52%
IKARIAN CAPITAL, LLC 05/15/2025 575.00 K $3.62 M   76.92% 0.49%
NORTHERN TRUST CORP 05/13/2025 566.20 K $3.56 M   17.27% 0.48%
EAM INVESTORS, LLC 05/13/2025 550.92 K $3.47 M   100.00% 0.47%
SILVERARC CAPITAL MANAGEMENT, LLC 05/14/2025 530.00 K $3.33 M   -27.82% 0.45%
RAYMOND JAMES FINANCIAL INC 05/13/2025 509.38 K $3.20 M   4,144.83% 0.43%
MORGAN STANLEY 05/15/2025 494.57 K $3.11 M   159.11% 0.42%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2025 440.00 K $2.77 M   -82.40% 0.37%
LOGOS GLOBAL MANAGEMENT LP 05/15/2025 424.72 K $2.67 B   -66.02% 0.36%
SUVRETTA CAPITAL MANAGEMENT, LLC 05/15/2025 340.16 K $2.14 M   100.00% 0.29%
PANAGORA ASSET MANAGEMENT INC 05/15/2025 339.90 K $2.14 M   182.54% 0.29%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 281.10 K $1.77 M   592.23% 0.24%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 275.70 K $1.73 M   109.66% 0.23%
05/12/2025 273.62 K $1.72 M   100.00% 0.23%
GOLDMAN SACHS GROUP INC 05/16/2025 211.87 K $1.33 M   -10.28% 0.18%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 207.52 K $1.31 M   19.91% 0.18%
CUBIST SYSTEMATIC STRATEGIES, LLC 05/15/2025 206.96 K $1.30 M   131.74% 0.18%
J. GOLDMAN & CO LP 05/15/2025 201.11 K $1.26 M   -62.59% 0.17%
05/15/2025 180.00 K $1.13 M   100.00% 0.15%
TEJARA CAPITAL LTD 05/13/2025 179.52 K $1.13 M   16.77% 0.15%
STATE OF WISCONSIN INVESTMENT BOARD 05/15/2025 175.15 K $1.10 M   171.54% 0.15%
BANK OF NEW YORK MELLON CORP 04/29/2025 166.08 K $1.04 M   18.44% 0.14%

Trevi Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 148 institutional investors and hedge funds held shares of Trevi Therapeutics, Inc.. The most heavily invested institutionals were:

NEA Management Company, LLC: 11.37 M

Frazier Life Sciences Management, L.P.: 10.26 M

BlackRock, Inc.: 5.31 M

Rubric Capital Management LP: 4.54 M

VANGUARD GROUP INC: 3.84 M

Vivo Capital, LLC: 3.49 M

74.93% of Trevi Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 93.59 M shares in the last 24 months. This purchase volume represents approximately $637.37 M in transactions.